AR and prostate carcinoma: A literature review focusing on AR, GATA3 and ZNF622 regulation of glycogenes identified a single paper reporting AR binding to a B3GNT5 promoter, using semi-quantitative PCR with ChIP in prostate cancer cell line LAPC-4 [74].